Latest Stories
Featured Stories
Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.
Feedback
All Stories
Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.
Surendra Rathaur
Acute Pancreatitis
Ahmedabad, Gujarat
Ahmedabad, Gujarat, India — Surendra Rathaur, a 34-year-old Senior Software Engineer from A…
Samip Desai
Chronic Calcific Pancreatitis
Ahmedabad, Gujarat
Ahmedabad, Gujarat, India — Samip Desai, a 38-year-old restaurateur from Ahmedabad, embarke…
Hardi Nayak
Acute Pancreatitis
Gandhinagar, Gujarat
Gandhinagar, Gujarat, India — Hardi Nayak, a 12-year-old student from Gandhinagar, found he…
Raj Khanapara
Chronic Pancreatitis
Rajkot, Gujarat
Rajkot, Gujarat, India — For Raj Khanapara, a 26-year-old businessman from Rajkot, the onse…
Ajay Vaghela
Recurrent Acute Pancreatitis
Ahmedabad, Gujarat
Ahmedabad, Gujarat, India — For Ajay Vaghela, a 30-year-old petrol pump business owner from…
Aditya Jain
Acute on Chronic Pancreatitis
Ahmedabad, Gujarat
Ahmedabad, Gujarat, India — At the age of 15, Aditya Jain, a student from Ahmedabad, faced …
Research
Our Research
At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.
Management of multi-relapsed chronic pancreatitis through Rasaushadhis: A case study
Chronic pancreatitis causes irreversible pancreatic damage with limited treatment success and significant mortality. This case highlights a patient managed with Ayurveda, achieving nine years symptom-free and no disease progression.
Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up
A 47-year-old diabetic male with high-risk AML-M3 relapsed after multiple chemotherapy treatments. In 1997, he opted for a pilot Ayurvedic study and was treated with Navajeevan, Kamadudha Rasa, and Keharuba Pisti. He achieved complete remission and has remained disease-free for 13 years without side effects from the alternative treatment.
Acute and Sub acute Toxicity Study of Ayurvedic Formulation (AYFs) Used for Migraine Treatment
This study tested the safety of five Ayurvedic formulations for migraine prevention in rats and mice. Acute and sub-acute toxicity studies showed no toxic effects at doses up to 10 times the human dose. A slight mortality in high-dose groups was unrelated to treatment. The formulations are considered safe, but further chronic toxicity studies are needed.
Scientific validated approach for application of Mandura bhasma A review
Mandura (iron rust) is purified and calcined in Ayurveda to create Mandura Bhasma, used for conditions like spleen and liver enlargement, jaundice, oedema, and anemia. Our study found that Prak-20 aligns with the classical dose schedule for Mandura Bhasma.
CA19-9 lowering effect of Ayurvedic Mineral Complex in the patients of Chronic Pancreatitis
CA19-9, a marker for pancreatic cancer, is elevated in pancreatitis and some gastrointestinal cancers. An Ayurvedic Mineral Complex (AMC) has shown promise in lowering CA19-9 levels in pancreatitis patients. This finding could lead to further research on AMC as a preventive therapy for pancreatic cancer in such patients. This study reports on 43 pancreatitis patients treated with AMC.
Integration of Ayurvedic formulations with iron folic acid in the treatment of nutritional anaemia among school going adolescents of Dehradun District
This study evaluated the effect of Ayurvedic preparations Sootshekhar Rasa (SR) and Sitopaladi Churna (SC) with iron and folic acid (IFA) on nutritional anaemia in 820 adolescents in Dehradun, India. After 90 days of treatment, all groups showed increased haemoglobin levels, with the best results in the group receiving SR + SC + IFA. No major side effects were reported, and the treatment led to sustainable improvements in anaemia.